New treatment option for Wilson's Disease
Official title Description of the Copper Concentration in Breast Milk in Women Treated for Wilson's Disease
ClinicalTrials.gov ID: NCT05183165
What this study is testing
- What it's testing
- Wilson's disease is a rare genetic disease, affecting less than 1,500 people in France. The transmission is autosomal recessive linked to an anomaly of the ATP7B gene on chromosome.This gene codes for an ATPase-type transmembrane protein involved in the transport of copper through the cell plasma member.This gene codes for an ATPase-type transmembrane protein involved in the transport of copper through the cell plasma member.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Criteria for inclusion :
- Patient aged 18 years or over.
- Wilson's disease fulfilling the criteria for the Leipzig score
- Pregnancy in progress whatever the term.
- Express consent to participate in the study.
See the full eligibility criteria
- Criteria for inclusion :
- Patient aged 18 years or over.
- Wilson's disease fulfilling the criteria for the Leipzig score
- Pregnancy in progress whatever the term.
- Express consent to participate in the study.
- Affiliate or beneficiary of a social security system. Criteria for non-inclusion :
- Liver transplant patient
- No affiliation to Social Security system
- VuInability to give free and informed consent
- Patient benefiting from a legal protection measure
The study team makes the final eligibility decision.
Where it's taking place
- Paris, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Paris, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.